871013-92-2 Usage
General Description
Tert-butyl 4-hydroxyisoindoline-2-carboxylate is a chemical compound with the molecular formula C14H17NO4. It is a ester derivative of 4-hydroxyisoindoline-2-carboxylic acid, and consists of a tert-butyl group attached to the nitrogen atom and a carboxylic acid group. tert-butyl 4-hydroxyisoindoline-2-carboxylate is used in organic synthesis as a building block for the preparation of various pharmaceuticals and agricultural chemicals. It has also shown potential antioxidant and antitumor activities, making it a subject of interest for further research in the field of medicinal chemistry. Additionally, its unique structure and reactivity make it a valuable intermediate in the production of specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 871013-92-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,0,1 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 871013-92:
(8*8)+(7*7)+(6*1)+(5*0)+(4*1)+(3*3)+(2*9)+(1*2)=152
152 % 10 = 2
So 871013-92-2 is a valid CAS Registry Number.
871013-92-2Relevant articles and documents
INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT
-
, (2021/12/28)
The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process: Formula (I) wherein R1, R2, R3, R4, R6
RHO KINASE INHIBITORS
-
, (2015/04/28)
The invention provides novel inhibitors of ROCK1 and/or ROCK2. Also provided are methods of treating diseases and disorders involving inhibiting ROCK1 and/or ROCK2. The present invention includes pharmaceutical compositions comprising the compounds of the invention and a pharmaceutically acceptable carrier and/or diluents. The present invention includes compositions comprising a substantially pure compound of the invention and a pharmaceutically acceptable salt, steroisomer, or hydrate thereof: and a pharmaceutically acceptable excipient and/or diluents.